Total Funding
84
75
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10804
Polyrizon is a biotechnology company that focuses on hydrogel-based nasal spray technologies.
Eyal S. Ron: Chief Technology OfficerPast Role: Gelesis, CTO (and Co-Founder)- Tomer Izraeli: Founder and CEO
About the Company
Polyrizon is a biotechnology company that develops intranasal medical products. It focuses on hydrogel-based nasal spray technologies that form protective barriers in the nasal cavity and enable intranasal delivery of active pharmaceutical ingredients. Its product development includes allergy, viral, and therapeutic delivery applications based on
proprietary platforms.
